400 related articles for article (PubMed ID: 21999760)
1. Opioid pharmacokinetic drug-drug interactions.
Overholser BR; Foster DR
Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the impact of drug-drug interactions associated with opioids.
Pergolizzi JV
Am J Manag Care; 2011 Sep; 17 Suppl 11():S288-92. PubMed ID: 21999761
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.
Coates S; Lazarus P
J Pharmacol Exp Ther; 2023 Nov; 387(2):150-169. PubMed ID: 37679047
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids.
Pergolizzi JV; Labhsetwar SA; Puenpatom RA; Joo S; Ben-Joseph RH; Summers KH
Pain Pract; 2011; 11(3):230-9. PubMed ID: 20807350
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and Disposition of Prescription Opioids: A Review.
DePriest AZ; Puet BL; Holt AC; Roberts A; Cone EJ
Forensic Sci Rev; 2015 Jul; 27(2):115-45. PubMed ID: 26227254
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of potential drug-drug interactions in opioid analgesics.
Summers KH; Puenpatom RA; Rajan N; Ben-Joseph R; Ohsfeldt R
J Med Econ; 2011; 14(4):390-6. PubMed ID: 21574905
[TBL] [Abstract][Full Text] [Related]
8. [Opioids. Pharmacology, clinic, prospectives for an extensive use].
Ginobbi P; Tirelli W; D'Angiolino G; Ciocca F; Centulio F; Pelagalli L; Marcelli ME; Arcuri E
Recenti Prog Med; 2000 Dec; 91(12):621-7. PubMed ID: 11194479
[No Abstract] [Full Text] [Related]
9. Best practices to reduce the risk of drug-drug interactions: opportunities for managed care.
Fanciullo GJ; Washington T
Am J Manag Care; 2011 Sep; 17 Suppl 11():S299-304. PubMed ID: 21999763
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic drug interactions of synthetic opiate analgesics.
Armstrong SC; Wynn GH; Sandson NB
Psychosomatics; 2009; 50(2):169-76. PubMed ID: 19377028
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of opioids in the treatment of chronic non-cancer pain.
Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fatal poisonings by prescription opioids.
Häkkinen M; Launiainen T; Vuori E; Ojanperä I
Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
Atluri S; Sudarshan G; Manchikanti L
Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
[TBL] [Abstract][Full Text] [Related]
15. Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.
French D; Wu A; Lynch K
Bioanalysis; 2011 Dec; 3(23):2603-12. PubMed ID: 22136049
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation.
Ji B; Liu S; Xue Y; He X; Man VH; Xie XQ; Wang J
Drugs R D; 2019 Sep; 19(3):297-305. PubMed ID: 31482303
[TBL] [Abstract][Full Text] [Related]
17. Management of drug-drug interactions: considerations for special populations--focus on opioid use in the elderly and long term care.
Lynch T
Am J Manag Care; 2011 Sep; 17 Suppl 11():S293-8. PubMed ID: 21999762
[TBL] [Abstract][Full Text] [Related]
18. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
Feng XQ; Zhu LL; Zhou Q
J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
[TBL] [Abstract][Full Text] [Related]
19. Observations on the urine metabolic profile of codeine in pain patients.
Yee DA; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053
[TBL] [Abstract][Full Text] [Related]
20. Is maternal opioid use hazardous to breast-fed infants?
Hendrickson RG; McKeown NJ
Clin Toxicol (Phila); 2012 Jan; 50(1):1-14. PubMed ID: 22148986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
